From: Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study
Variable | Multivariable logistic regression estimate | p | OR (95% CI) |
---|---|---|---|
Voriconazole | |||
 Total daily dose (mg) | 0.001 | 0.64 |  |
 mg/kg/dose | −0.79 | 0.33 |  |
 mg/kg/day | 0.44 | 0.29 |  |
 Weight | −0.006 | 0.78 |  |
 Concomitant H2RA/PPI | 0.21 | 0.23 | 1.53 (0.77–3.09) |
 Critically ill | −0.06 | 0.67 | 0.88 (0.51–1.53) |
 Immunocompromised | 0.002 | 0.99 | 1.003 (0.56–1.79) |
Posaconazole | |||
 Total daily dose (mg) | 0.009 | 0.07 |  |
 mg/kg/dose | −0.076 | 0.74 |  |
 mg/kg/day | −0.16 | 0.62 |  |
 Weight | −0.015 | 0.65 |  |
 Concomitant H2RA/PPI | −1.20 | 0.04 | 0.09 (0.007–0.75) |
 Critically ill | −0.34 | 0.43 | 0.05 (0.07–2.45) |
 Immunocompromised | −0.16 | 0.73 | 0.73 (0.11–4.53) |